BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sochor M, Basova P, Pesta M, Dusilkova N, Bartos J, Burda P, Pospisil V, Stopka T. Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum. BMC Cancer. 2014;14:448. [PMID: 24938880 DOI: 10.1186/1471-2407-14-448] [Cited by in Crossref: 110] [Cited by in F6Publishing: 109] [Article Influence: 13.8] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Shou H, Wang Q, Liu S. Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma. Gene 2019;694:76-82. [DOI: 10.1016/j.gene.2018.12.076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
2 Wang H, Peng R, Wang J, Qin Z, Xue L. Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage. Clin Epigenetics 2018;10:59. [PMID: 29713393 DOI: 10.1186/s13148-018-0492-1] [Cited by in Crossref: 188] [Cited by in F6Publishing: 173] [Article Influence: 47.0] [Reference Citation Analysis]
3 Indrieri A, Carrella S, Carotenuto P, Banfi S, Franco B. The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer. Int J Mol Sci 2020;21:E2092. [PMID: 32197476 DOI: 10.3390/ijms21062092] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
4 Bahmanpour Z, Sheervalilou R, Choupani J, Shekari Khaniani M, Montazeri V, Mansoori Derakhshan S. A new insight on serum microRNA expression as novel biomarkers in breast cancer patients. J Cell Physiol 2019;234:19199-211. [PMID: 31026062 DOI: 10.1002/jcp.28656] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
5 Li Q, Li X, Wang L, Zhang Y, Chen L. miR-98-5p Acts as a Target for Alzheimer's Disease by Regulating Aβ Production Through Modulating SNX6 Expression. J Mol Neurosci 2016;60:413-20. [PMID: 27541017 DOI: 10.1007/s12031-016-0815-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
6 Wang X, Chen X, Meng Q, Jing H, Lu H, Yang Y, Cai L, Zhao Y. MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC. Sci Rep 2015;5:17618. [PMID: 26620926 DOI: 10.1038/srep17618] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
7 Sato J, Shimomura A, Kawauchi J, Matsuzaki J, Yamamoto Y, Takizawa S, Sakamoto H, Ohno M, Narita Y, Ochiya T, Tamura K. Brain metastasis-related microRNAs in patients with advanced breast cancer. PLoS One 2019;14:e0221538. [PMID: 31603918 DOI: 10.1371/journal.pone.0221538] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
8 Graveel CR, Calderone HM, Westerhuis JJ, Winn ME, Sempere LF. Critical analysis of the potential for microRNA biomarkers in breast cancer management. Breast Cancer (Dove Med Press) 2015;7:59-79. [PMID: 25759599 DOI: 10.2147/BCTT.S43799] [Cited by in Crossref: 5] [Cited by in F6Publishing: 35] [Article Influence: 0.7] [Reference Citation Analysis]
9 Erbes T, Hirschfeld M, Rücker G, Jaeger M, Boas J, Iborra S, Mayer S, Gitsch G, Stickeler E. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker. BMC Cancer. 2015;15:193. [PMID: 25886191 DOI: 10.1186/s12885-015-1190-4] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 10.0] [Reference Citation Analysis]
10 Fish EJ, Irizarry KJ, DeInnocentes P, Ellis CJ, Prasad N, Moss AG, Curt Bird R. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks. BMC Cancer 2018;18:832. [PMID: 30126376 DOI: 10.1186/s12885-018-4750-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
11 Khalighfard S, Alizadeh AM, Irani S, Omranipour R. Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients. Sci Rep 2018;8:17981. [PMID: 30568292 DOI: 10.1038/s41598-018-36321-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 11.5] [Reference Citation Analysis]
12 Rapado-González Ó, López-López R, López-Cedrún JL, Triana-Martínez G, Muinelo-Romay L, Suárez-Cunqueiro MM. Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy. Cells 2019;8:E1653. [PMID: 31861130 DOI: 10.3390/cells8121653] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
13 Ravelli A, Reuben JM, Lanza F, Anfossi S, Cappelletti MR, Zanotti L, Gobbi A, Senti C, Brambilla P, Milani M, Spada D, Pedrazzoli P, Martino M, Bottini A, Generali D; Solid Tumor Working Party of European Blood and Marrow Transplantation Society (EBMT). Breast cancer circulating biomarkers: advantages, drawbacks, and new insights. Tumour Biol 2015;36:6653-65. [PMID: 26307395 DOI: 10.1007/s13277-015-3944-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
14 Zou X, Wei J, Huang Z, Zhou X, Lu Z, Zhu W, Miao Y. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis. Cancer Med 2019;8:2810-22. [PMID: 31006985 DOI: 10.1002/cam4.2145] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 11.7] [Reference Citation Analysis]
15 Wang L, Wang YX, Chen LP, Ji ML. Upregulation of microRNA-181b inhibits CCL18-induced breast cancer cell metastasis and invasion via the NF-κB signaling pathway. Oncol Lett 2016;12:4411-8. [PMID: 28105154 DOI: 10.3892/ol.2016.5230] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
16 Bai SY, Ji R, Wei H, Guo QH, Yuan H, Chen ZF, Wang YP, Liu Z, Yang XY, Zhou YN. Serum miR-551b-3p is a potential diagnostic biomarker for gastric cancer. Turk J Gastroenterol 2019;30:415-9. [PMID: 31060996 DOI: 10.5152/tjg.2019.17875] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Fu SW, Lee W, Coffey C, Lean A, Wu X, Tan X, Man YG, Brem RF. miRNAs as potential biomarkers in early breast cancer detection following mammography. Cell Biosci 2016;6:6. [PMID: 26819702 DOI: 10.1186/s13578-016-0071-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
18 Mueller S, Dennison G, Liu S. An Assessment on Ethanol-Blended Gasoline/Diesel Fuels on Cancer Risk and Mortality. Int J Environ Res Public Health 2021;18:6930. [PMID: 34203568 DOI: 10.3390/ijerph18136930] [Reference Citation Analysis]
19 Nassar FJ, Nasr R, Talhouk R. MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction. Pharmacol Ther 2017;172:34-49. [PMID: 27916656 DOI: 10.1016/j.pharmthera.2016.11.012] [Cited by in Crossref: 103] [Cited by in F6Publishing: 109] [Article Influence: 17.2] [Reference Citation Analysis]
20 Tian Y, Fu X, Li Q, Wang Y, Fan D, Zhou Q, Kuang W, Shen L. MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4. Mol Med Rep 2018;18:5603-13. [PMID: 30365052 DOI: 10.3892/mmr.2018.9572] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
21 Shimomura A, Shiino S, Kawauchi J, Takizawa S, Sakamoto H, Matsuzaki J, Ono M, Takeshita F, Niida S, Shimizu C, Fujiwara Y, Kinoshita T, Tamura K, Ochiya T. Novel combination of serum microRNA for detecting breast cancer in the early stage. Cancer Sci 2016;107:326-34. [PMID: 26749252 DOI: 10.1111/cas.12880] [Cited by in Crossref: 156] [Cited by in F6Publishing: 139] [Article Influence: 26.0] [Reference Citation Analysis]
22 Kaboli PJ, Rahmat A, Ismail P, Ling K. MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment. Pharmacological Research 2015;97:104-21. [DOI: 10.1016/j.phrs.2015.04.015] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 10.9] [Reference Citation Analysis]
23 Vychytilova-Faltejskova P, Slaby O. Circulating Blood-Borne microRNAs as Biomarkers in Solid Tumors. Exp Suppl 2015;106:75-122. [PMID: 26608200 DOI: 10.1007/978-3-0348-0955-9_4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Li J, Guan X, Fan Z, Ching LM, Li Y, Wang X, Cao WM, Liu DX. Non-Invasive Biomarkers for Early Detection of Breast Cancer. Cancers (Basel) 2020;12:E2767. [PMID: 32992445 DOI: 10.3390/cancers12102767] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
25 Robinson CL, Zhang L, Schütz LF, Totty ML, Spicer LJ. MicroRNA 221 expression in theca and granulosa cells: hormonal regulation and function. J Anim Sci 2018;96:641-52. [PMID: 29385487 DOI: 10.1093/jas/skx069] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
26 Cui S, Liao X, Ye C, Yin X, Liu M, Hong Y, Yu M, Liu Y, Liang H, Zhang CY, Chen X. ING5 suppresses breast cancer progression and is regulated by miR-24. Mol Cancer 2017;16:89. [PMID: 28490335 DOI: 10.1186/s12943-017-0658-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
27 Esplugas R, Arenas M, Serra N, Bellés M, Bonet M, Gascón M, Vallvé JC, Linares V. Effect of radiotherapy on the expression of cardiovascular disease-related miRNA-146a, -155, -221 and -222 in blood of women with breast cancer. PLoS One 2019;14:e0217443. [PMID: 31150454 DOI: 10.1371/journal.pone.0217443] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Braicu C, Gulei D, Raduly L, Harangus A, Rusu A, Berindan-Neagoe I. Altered expression of miR-181 affects cell fate and targets drug resistance-related mechanisms. Mol Aspects Med 2019;70:90-105. [PMID: 31703947 DOI: 10.1016/j.mam.2019.10.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
29 Bottani M, Banfi G, Lombardi G. Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma. J Clin Med 2019;8:E1661. [PMID: 31614612 DOI: 10.3390/jcm8101661] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
30 Anfossi S, Babayan A, Pantel K, Calin GA. Clinical utility of circulating non-coding RNAs - an update. Nat Rev Clin Oncol 2018;15:541-63. [PMID: 29784926 DOI: 10.1038/s41571-018-0035-x] [Cited by in Crossref: 185] [Cited by in F6Publishing: 185] [Article Influence: 61.7] [Reference Citation Analysis]
31 Li Q, Liu M, Ma F, Luo Y, Cai R, Wang L, Xu N, Xu B. Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel. PLoS One 2014;9:e104870. [PMID: 25137071 DOI: 10.1371/journal.pone.0104870] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
32 Jafari SH, Saadatpour Z, Salmaninejad A, Momeni F, Mokhtari M, Nahand JS, Rahmati M, Mirzaei H, Kianmehr M. Breast cancer diagnosis: Imaging techniques and biochemical markers. J Cell Physiol 2018;233:5200-13. [PMID: 29219189 DOI: 10.1002/jcp.26379] [Cited by in Crossref: 104] [Cited by in F6Publishing: 98] [Article Influence: 26.0] [Reference Citation Analysis]
33 McAnena P, Lowery A, Kerin MJ. Role of micro-RNAs in breast cancer surgery. Br J Surg 2018;105:e19-30. [PMID: 29341144 DOI: 10.1002/bjs.10790] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
34 Pagacz K, Kucharski P, Smyczynska U, Grabia S, Chowdhury D, Fendler W. A systemic approach to screening high-throughput RT-qPCR data for a suitable set of reference circulating miRNAs. BMC Genomics 2020;21:111. [PMID: 32005151 DOI: 10.1186/s12864-020-6530-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
35 Kumar S, Reddy PH. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease? Biochim Biophys Acta 2016;1862:1617-27. [PMID: 27264337 DOI: 10.1016/j.bbadis.2016.06.001] [Cited by in Crossref: 111] [Cited by in F6Publishing: 117] [Article Influence: 18.5] [Reference Citation Analysis]
36 Huang SK, Luo Q, Peng H, Li J, Zhao M, Wang J, Gu YY, Li Y, Yuan P, Zhao GH, Huang CZ. A Panel of Serum Noncoding RNAs for the Diagnosis and Monitoring of Response to Therapy in Patients with Breast Cancer. Med Sci Monit 2018;24:2476-88. [PMID: 29683112 DOI: 10.12659/msm.909453] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
37 Abolghasemi M, Tehrani SS, Yousefi T, Karimian A, Mahmoodpoor A, Ghamari A, Jadidi-Niaragh F, Yousefi M, Kafil HS, Bastami M, Edalati M, Eyvazi S, Naghizadeh M, Targhazeh N, Yousefi B, Safa A, Majidinia M, Rameshknia V. MicroRNAs in breast cancer: Roles, functions, and mechanism of actions. J Cell Physiol 2020;235:5008-29. [PMID: 31724738 DOI: 10.1002/jcp.29396] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
38 Ji Q, Wang X, Cai J, Du X, Sun H, Zhang N. MiR-22-3p Regulates Amyloid β Deposit in Mice Model of Alzheimer's Disease by Targeting Mitogen-activated Protein Kinase 14. Curr Neurovasc Res 2019;16:473-80. [PMID: 31713484 DOI: 10.2174/1567202616666191111124516] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
39 Takahashi RU, Miyazaki H, Ochiya T. The Roles of MicroRNAs in Breast Cancer. Cancers (Basel). 2015;7:598-616. [PMID: 25860815 DOI: 10.3390/cancers7020598] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 12.4] [Reference Citation Analysis]
40 Pop-bica C, Pintea S, Cojocneanu-petric R, Del Sal G, Piazza S, Wu Z, Alencar AJ, Lossos IS, Berindan-neagoe I, Calin GA. MiR-181 family-specific behavior in different cancers: a meta-analysis view. Cancer Metastasis Rev 2018;37:17-32. [DOI: 10.1007/s10555-017-9714-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
41 Michael JV, Wurtzel JGT, Mao GF, Rao AK, Kolpakov MA, Sabri A, Hoffman NE, Rajan S, Tomar D, Madesh M, Nieman MT, Yu J, Edelstein LC, Rowley JW, Weyrich AS, Goldfinger LE. Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth. Blood. 2017;130:567-580. [PMID: 28500171 DOI: 10.1182/blood-2016-11-751099] [Cited by in Crossref: 99] [Cited by in F6Publishing: 101] [Article Influence: 19.8] [Reference Citation Analysis]
42 Khodadadi-Jamayran A, Akgol-Oksuz B, Afanasyeva Y, Heguy A, Thompson M, Ray K, Giro-Perafita A, Sánchez I, Wu X, Tripathy D, Zeleniuch-Jacquotte A, Tsirigos A, Esteva FJ. Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process. Oncotarget 2018;9:12868-78. [PMID: 29560116 DOI: 10.18632/oncotarget.24403] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
43 Salvador MA, Birnbaum D, Charafe-Jauffret E, Ginestier C. Breast cancer stem cells programs: enter the (non)-code. Brief Funct Genomics 2016;15:186-99. [PMID: 26955842 DOI: 10.1093/bfgp/elw003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
44 Papadaki C, Thomopoulou K, Monastirioti A, Koronakis G, Papadaki MA, Rounis K, Vamvakas L, Nikolaou C, Mavroudis D, Agelaki S. MicroRNAs Regulating Tumor and Immune Cell Interactions in the Prediction of Relapse in Early Stage Breast Cancer. Biomedicines 2021;9:421. [PMID: 33924670 DOI: 10.3390/biomedicines9040421] [Reference Citation Analysis]
45 Larrea E, Sole C, Manterola L, Goicoechea I, Armesto M, Arestin M, Caffarel MM, Araujo AM, Araiz M, Fernandez-Mercado M, Lawrie CH. New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies. Int J Mol Sci 2016;17:E627. [PMID: 27128908 DOI: 10.3390/ijms17050627] [Cited by in Crossref: 139] [Cited by in F6Publishing: 134] [Article Influence: 23.2] [Reference Citation Analysis]
46 Bertoli G, Cava C, Castiglioni I. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer. Scand J Clin Lab Invest Suppl 2016;245:S34-9. [PMID: 27435502 DOI: 10.1080/00365513.2016.1208444] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
47 Wang Y, Zhang G, Hao X, Ma Y, Ma M, Yan X, Jiang X, Bie F, Yuan N. RETRACTED: Potential biomarker for breast cancer screening: A systematic review and meta-analysis. Future Generation Computer Systems 2019;91:518-26. [DOI: 10.1016/j.future.2018.09.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
48 Fish EJ, Martinez-Romero EG, DeInnocentes P, Koehler JW, Prasad N, Smith AN, Bird RC. Circulating microRNA as biomarkers of canine mammary carcinoma in dogs. J Vet Intern Med 2020;34:1282-90. [PMID: 32342546 DOI: 10.1111/jvim.15764] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Delsin LEA, Roberto GM, Fedatto PF, Engel EE, Scrideli CA, Tone LG, Brassesco MS. Downregulated Adhesion-Associated microRNAs as Prognostic Predictors in Childhood Osteosarcoma. Pathol Oncol Res 2019;25:11-20. [DOI: 10.1007/s12253-017-0316-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
50 Arabkari V, Clancy E, Dwyer RM, Kerin MJ, Kalinina O, Holian E, Newell J, Smith TJ. Relative and Absolute Expression Analysis of MicroRNAs Associated with Luminal A Breast Cancer- A Comparison. Pathol Oncol Res 2020;26:833-44. [PMID: 30840191 DOI: 10.1007/s12253-019-00627-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
51 Gao S, Lu X, Ma J, Zhou Q, Tang R, Fu Z, Wang F, Lv M, Lu C. Comprehensive Analysis of lncRNA and miRNA Regulatory Network Reveals Potential Prognostic Non-coding RNA Involved in Breast Cancer Progression. Front Genet 2021;12:621809. [PMID: 34220926 DOI: 10.3389/fgene.2021.621809] [Reference Citation Analysis]
52 Klinge CM. Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication. Noncoding RNA. 2018;4. [PMID: 30545127 DOI: 10.3390/ncrna4040040] [Cited by in Crossref: 39] [Cited by in F6Publishing: 51] [Article Influence: 9.8] [Reference Citation Analysis]
53 Aggarwal V, Priyanka K, Tuli HS. Emergence of Circulating MicroRNAs in Breast Cancer as Diagnostic and Therapeutic Efficacy Biomarkers. Mol Diagn Ther 2020;24:153-73. [DOI: 10.1007/s40291-020-00447-w] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
54 Li FZ, Zang WQ. Knockdown of lncRNAXLOC_001659 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells. World J Gastroenterol 2019; 25(42): 6299-6310 [PMID: 31754291 DOI: 10.3748/wjg.v25.i42.6299] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
55 Li H, Wu Q, Li T, Liu C, Xue L, Ding J, Shi Y, Fan D. The miR-17-92 cluster as a potential biomarker for the early diagnosis of gastric cancer: evidence and literature review. Oncotarget 2017;8:45060-71. [PMID: 28178677 DOI: 10.18632/oncotarget.15023] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
56 Wang W, Zhang E, Lin C. MicroRNAs in tumor angiogenesis. Life Sci 2015;136:28-35. [PMID: 26144623 DOI: 10.1016/j.lfs.2015.06.025] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
57 Li S, Xu JJ, Zhang QY. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer. Cancer Sci 2019;110:3098-109. [PMID: 31389121 DOI: 10.1111/cas.14164] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
58 Yu DD, Lv MM, Chen WX, Zhong SL, Zhang XH, Chen L, Ma TF, Tang JH, Zhao JH. Role of miR-155 in drug resistance of breast cancer. Tumour Biol 2015;36:1395-401. [PMID: 25744731 DOI: 10.1007/s13277-015-3263-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
59 Dong QG, Yang YC. Clinical significance of abnormal expression of miR-92a in serum of gastric cancer patients. Shijie Huaren Xiaohua Zazhi 2014; 22(29): 4487-4491 [DOI: 10.11569/wcjd.v22.i29.4487] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
60 Ozawa PMM, Jucoski TS, Vieira E, Carvalho TM, Malheiros D, Ribeiro EMSF. Liquid biopsy for breast cancer using extracellular vesicles and cell-free microRNAs as biomarkers. Transl Res 2020;223:40-60. [PMID: 32413499 DOI: 10.1016/j.trsl.2020.04.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
61 Yuan D, Li K, Zhu K, Yan R, Dang C. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer. Cancer Biol Ther. 2015;16:268-275. [PMID: 25629978 DOI: 10.1080/15384047.2014.1002327] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 6.9] [Reference Citation Analysis]
62 Han JG, Jiang YD, Zhang CH, Yang YM, Pang D, Song YN, Zhang GQ. A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer. Ann Surg Treat Res 2017;92:55-66. [PMID: 28203552 DOI: 10.4174/astr.2017.92.2.55] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 8.4] [Reference Citation Analysis]
63 Zou P, Ding J, Fu S. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma. Pathol Res Pract 2017;213:194-8. [PMID: 28214202 DOI: 10.1016/j.prp.2016.12.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
64 Zubor P, Kubatka P, Kajo K, Dankova Z, Polacek H, Bielik T, Kudela E, Samec M, Liskova A, Vlcakova D, Kulkovska T, Stastny I, Holubekova V, Bujnak J, Laucekova Z, Büsselberg D, Adamek M, Kuhn W, Danko J, Golubnitschaja O. Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management. Int J Mol Sci 2019;20:E2878. [PMID: 31200461 DOI: 10.3390/ijms20122878] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
65 Ribatti D, Tamma R. Epigenetic control of tumor angiogenesis. Microcirculation 2020;27:e12602. [PMID: 31863494 DOI: 10.1111/micc.12602] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
66 Giussani M, Ciniselli CM, De Cecco L, Lecchi M, Dugo M, Gargiuli C, Mariancini A, Mancinelli E, Cosentino G, Veneroni S, Paolini B, Orlandi R, Gennaro M, Iorio MV, Depretto C, Ferranti C, Sozzi G, Sensi M, Colombo MP, Scaperrotta G, Tagliabue E, Verderio P. Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast Lesions for Which Biopsy Is Recommended. Cancers (Basel) 2021;13:4028. [PMID: 34439180 DOI: 10.3390/cancers13164028] [Reference Citation Analysis]
67 Xie S, Wang Y, Liu H, Wang M, Yu H, Qiao Y, Li F, Xie X, Zhang J. Diagnostic significance of circulating multiple miRNAs in breast cancer: a systematic review and meta-analysis. Biomarkers in Medicine 2016;10:661-74. [DOI: 10.2217/bmm-2015-0017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
68 Bertoli G, Cava C, Castiglioni I. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer. Theranostics. 2015;5:1122-1143. [PMID: 26199650 DOI: 10.7150/thno.11543] [Cited by in Crossref: 406] [Cited by in F6Publishing: 398] [Article Influence: 58.0] [Reference Citation Analysis]
69 Zhang X, Gu Y, Liu X, Yu Y, Shi J, Yu Q, Sun H, Kanu JS, Zhan S, Liu Y. Association of Pre-miR-146a rs2910164 Polymorphism with Papillary Thyroid Cancer. Int J Endocrinol 2015;2015:802562. [PMID: 26664358 DOI: 10.1155/2015/802562] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
70 Hayes EL, Lewis-Wambi JS. Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA. Breast Cancer Res 2015;17:40. [PMID: 25849966 DOI: 10.1186/s13058-015-0542-y] [Cited by in Crossref: 104] [Cited by in F6Publishing: 106] [Article Influence: 14.9] [Reference Citation Analysis]
71 Zhao Y, Song Y, Yao L, Song G, Teng C. Circulating microRNAs: Promising Biomarkers Involved in Several Cancers and Other Diseases. DNA and Cell Biology 2017;36:77-94. [DOI: 10.1089/dna.2016.3426] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
72 Ardizzone A, Calabrese G, Campolo M, Filippone A, Giuffrida D, Esposito F, Colarossi C, Cuzzocrea S, Esposito E, Paterniti I. Role of miRNA-19a in Cancer Diagnosis and Poor Prognosis. Int J Mol Sci 2021;22:4697. [PMID: 33946718 DOI: 10.3390/ijms22094697] [Reference Citation Analysis]
73 Feliciano A, González L, Garcia-Mayea Y, Mir C, Artola M, Barragán N, Martín R, Altés A, Castellvi J, Benavente S, Ramón Y Cajal S, Espinosa-Bravo M, Cortés J, Rubio IT, LLeonart ME. Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals. Front Oncol 2020;10:586268. [PMID: 33224883 DOI: 10.3389/fonc.2020.586268] [Reference Citation Analysis]
74 Wang XH, Gan CZ, Xie JY. Inhibition of miR-24 suppresses malignancy of human non-small cell lung cancer cells by targeting WWOX in vitro and in vivo. Thorac Cancer 2018;9:1583-93. [PMID: 30307120 DOI: 10.1111/1759-7714.12824] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
75 Gong JP, Yang L, Tang JW, Sun P, Hu Q, Qin JW, Xu XM, Sun BC, Tang JH. Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9. Oncol Lett 2016;12:3905-11. [PMID: 27895747 DOI: 10.3892/ol.2016.5139] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
76 Malczewska A, Frampton AE, Mato Prado M, Ameri S, Dabrowska AF, Zagorac S, Clift AK, Kos-Kudła B, Faiz O, Stebbing J, Castellano L, Frilling A. Circulating MicroRNAs in Small-bowel Neuroendocrine Tumors: A Potential Tool for Diagnosis and Assessment of Effectiveness of Surgical Resection. Ann Surg 2021;274:e1-9. [PMID: 31373926 DOI: 10.1097/SLA.0000000000003502] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
77 Xu D, Zhu H, Wang C, Zhao W, Liu G, Bao G, Cui D, Fan J, Wang F, Jin H, Cui Z. SphK2 over-expression promotes osteosarcoma cell growth. Oncotarget 2017;8:105525-35. [PMID: 29285269 DOI: 10.18632/oncotarget.22314] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
78 Jiang Y, Gai Y, Long Y, Liu Q, Liu C, Zhang Y, Lan X. Application and Evaluation of [99mTc]-Labeled Peptide Nucleic Acid Targeting MicroRNA-155 in Breast Cancer Imaging. Mol Imaging 2020;19:1536012120916124. [PMID: 32559121 DOI: 10.1177/1536012120916124] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Grimaldi AM, Incoronato M. Clinical Translatability of "Identified" Circulating miRNAs for Diagnosing Breast Cancer: Overview and Update. Cancers (Basel) 2019;11:E901. [PMID: 31252695 DOI: 10.3390/cancers11070901] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
80 Haier J, Ströse A, Matuszcak C, Hummel R. miR clusters target cellular functional complexes by defining their degree of regulatory freedom. Cancer Metastasis Rev 2016;35:289-322. [PMID: 26970968 DOI: 10.1007/s10555-016-9617-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
81 Encarnación-Medina J, Ortiz C, Vergne R, Padilla L, Matta J. MicroRNA Expression Changes in Women with Breast Cancer Stratified by DNA Repair Capacity Levels. J Oncol 2019;2019:7820275. [PMID: 31191653 DOI: 10.1155/2019/7820275] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
82 Tian F, Shen Y, Chen Z, Li R, Lu J, Ge Q. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer. Gene 2016;591:338-43. [DOI: 10.1016/j.gene.2016.06.014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
83 Gao S, Wang Y, Wang M, Li Z, Zhao Z, Wang RX, Wu R, Yuan Z, Cui R, Jiao K, Wang L, Ouyang L, Liu R. MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer. Oncotarget 2017;8:41451-64. [PMID: 28562349 DOI: 10.18632/oncotarget.17816] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
84 Sui X, Wang X, Han W, Li D, Xu Y, Lou F, Zhou J, Gu X, Zhu J, Zhang C, Pan H. MicroRNAs-mediated cell fate in triple negative breast cancers. Cancer Lett 2015;361:8-12. [PMID: 25748387 DOI: 10.1016/j.canlet.2015.02.048] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
85 Bahreini F, Jabbari P, Gossing W, Aziziyan F, Frohme M, Rezaei N. The role of noncoding RNAs in pituitary adenoma. Epigenomics 2021;13:1421-37. [PMID: 34558980 DOI: 10.2217/epi-2021-0165] [Reference Citation Analysis]
86 Dusílková N, Bašová P, Polívka J, Kodet O, Kulvait V, Pešta M, Trněný M, Stopka T. Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas. Int J Mol Sci 2017;18:E2136. [PMID: 29036928 DOI: 10.3390/ijms18102136] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
87 Katoh M. Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases. Front Cell Dev Biol 2014;2:61. [PMID: 25364765 DOI: 10.3389/fcell.2014.00061] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
88 Wood ME, Farina NH, Ahern TP, Cuke ME, Stein JL, Stein GS, Lian JB. Towards a more precise and individualized assessment of breast cancer risk. Aging (Albany NY) 2019;11:1305-16. [PMID: 30787204 DOI: 10.18632/aging.101803] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
89 Heydari N, Nikbakhsh N, Sadeghi F, Farnoush N, Khafri S, Bastami M, Parsian H. Overexpression of serum MicroRNA-140-3p in premenopausal women with newly diagnosed breast cancer. Gene 2018;655:25-9. [PMID: 29474861 DOI: 10.1016/j.gene.2018.02.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
90 Zhang Y, Guo X, Li Z, Li B, Li Z, Li R, Guo Q, Xiong L, Yu L, Zhao J, Lin N. A systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma. RNA Biol 2015;12:643-57. [PMID: 25985117 DOI: 10.1080/15476286.2015.1022702] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
91 Maierthaler M, Benner A, Hoffmeister M, Surowy H, Jansen L, Knebel P, Chang-Claude J, Brenner H, Burwinkel B. Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer. Int J Cancer. 2017;140:176-187. [PMID: 27632639 DOI: 10.1002/ijc.30433] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 9.2] [Reference Citation Analysis]
92 Eastlack SC, Alahari SK. MicroRNA and Breast Cancer: Understanding Pathogenesis, Improving Management. Noncoding RNA 2015;1:17-43. [PMID: 29861413 DOI: 10.3390/ncrna1010017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
93 Zhang L, Xu Y, Jin X, Wang Z, Wu Y, Zhao D, Chen G, Li D, Wang X, Cao H, Xie Y, Liang Z. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer. Breast Cancer Res Treat 2015;154:423-34. [DOI: 10.1007/s10549-015-3591-0] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 8.6] [Reference Citation Analysis]
94 Lv L, An X, Li H, Ma L. Effect of miR-155 knockdown on the reversal of doxorubicin resistance in human lung cancer A549/dox cells. Oncol Lett 2016;11:1161-6. [PMID: 26893712 DOI: 10.3892/ol.2015.3995] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
95 Hou Y, Wang J, Wang X, Shi S, Wang W, Chen Z. Appraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection: A Meta-Analysis. Medicine (Baltimore) 2016;95:e2450. [PMID: 26765436 DOI: 10.1097/MD.0000000000002450] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
96 Mathe A, Scott RJ, Avery-Kiejda KA. MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer. Int J Mol Sci 2015;16:28347-76. [PMID: 26633365 DOI: 10.3390/ijms161226090] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
97 Hawa Z, Haque I, Ghosh A, Banerjee S, Harris L, Banerjee SK. The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression. Int J Mol Sci 2016;17:E809. [PMID: 27240340 DOI: 10.3390/ijms17060809] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
98 Nakamura K, Hiyake N, Hamada T, Yokoyama S, Mori K, Yamashiro K, Beppu M, Sagara Y, Sagara Y, Sugiura T. Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis. Cancers (Basel) 2021;13:449. [PMID: 33504017 DOI: 10.3390/cancers13030449] [Reference Citation Analysis]
99 Kim KS, Park JI, Oh N, Cho HJ, Park JH, Park KS. ELK3 expressed in lymphatic endothelial cells promotes breast cancer progression and metastasis through exosomal miRNAs. Sci Rep 2019;9:8418. [PMID: 31182803 DOI: 10.1038/s41598-019-44828-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
100 Guo Y, Li D, Li J, Yang N, Wang D. Expression and Significance of MicroRNA155 in Serum of Patients with Cerebral Small Vessel Disease. J Korean Neurosurg Soc 2020;63:463-9. [PMID: 32156102 DOI: 10.3340/jkns.2019.0179] [Reference Citation Analysis]
101 Bašová P, Pešta M, Sochor M, Stopka T. Prediction Potential of Serum miR-155 and miR-24 for Relapsing Early Breast Cancer. Int J Mol Sci 2017;18:E2116. [PMID: 28994735 DOI: 10.3390/ijms18102116] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
102 Peng Y, Huang D, Ma K, Deng X, Shao Z. MiR-19a as a prognostic indicator for cancer patients: a meta-analysis. Biosci Rep 2019;39:BSR20182370. [PMID: 31015372 DOI: 10.1042/BSR20182370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
103 Petri BJ, Klinge CM. Regulation of breast cancer metastasis signaling by miRNAs. Cancer Metastasis Rev 2020;39:837-86. [PMID: 32577859 DOI: 10.1007/s10555-020-09905-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
104 Lynch SM, McKenna MM, Walsh CP, McKenna DJ. miR-24 regulates CDKN1B/p27 expression in prostate cancer. Prostate 2016;76:637-48. [PMID: 26847530 DOI: 10.1002/pros.23156] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
105 Guo F, Tang C, Li Y, Liu Y, Lv P, Wang W, Mu Y. The interplay of LncRNA ANRIL and miR-181b on the inflammation-relevant coronary artery disease through mediating NF-κB signalling pathway. J Cell Mol Med 2018;22:5062-75. [PMID: 30079603 DOI: 10.1111/jcmm.13790] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
106 Sun XH, Song MF, Song HD, Wang YW, Luo MJ, Yin LM. miR‑155 mediates inflammatory injury of hippocampal neuronal cells via the activation of microglia. Mol Med Rep 2019;19:2627-35. [PMID: 30720115 DOI: 10.3892/mmr.2019.9917] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
107 Raghu A, Rao DM, Thangarajan R, Mani S. Prognostic Implications of microRNA-155, -133a, -21 and -205 in Breast Cancer Patients' Plasma. Microrna 2021. [PMID: 34238179 DOI: 10.2174/2211536610666210707114843] [Reference Citation Analysis]
108 Hamam R, Hamam D, Alsaleh KA, Kassem M, Zaher W, Alfayez M, Aldahmash A, Alajez NM. Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers. Cell Death Dis 2017;8:e3045. [PMID: 28880270 DOI: 10.1038/cddis.2017.440] [Cited by in Crossref: 161] [Cited by in F6Publishing: 159] [Article Influence: 32.2] [Reference Citation Analysis]
109 Grimaldi AM, Nuzzo S, Condorelli G, Salvatore M, Incoronato M. Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review. Int J Mol Sci 2020;21:E5834. [PMID: 32823863 DOI: 10.3390/ijms21165834] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
110 Wang JL, Wang X, Yang D, Shi WJ. The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma. Yonsei Med J 2016;57:298-305. [PMID: 26847279 DOI: 10.3349/ymj.2016.57.2.298] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]